THE Therapeutic Goods Administration has tested a product labelled Semenax capsules and found it contains the undeclared substance Yohimbine, a prescription-only prohibited import.
The TGA warns that the capsules may contain harmful ingredients.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Dec 17